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Introduction 
Obesity is  considered to be one of the modifiable cardiovascular risk factors, while weight 
loss is generally associated with a beneficial effect on markers of cardiovascular risk. 
Besides subcutaneous adipose tissue, ectopic fat depots such as epicardial adipose tissue 
(EAT) or perivascular adipose tissue (PVAT) are of particular interest as several studies 
point out a strong association between the amount of EAT and PVAT and atherosclerosis. 
Adipokines, which represent a series of hormones and cytokines secreted by adipose tissue 
and mediating their effects on endocrine or paracrine way, seem to explain this correlation. 
Thus, the function of adipose tissue extends far beyond energy storage or mechanical 
protection, being rather an important  endocrine organ. 
Purpose 
Elucidation of the role of adipokines in the pathogenesis of atherosclerosis. 
  
Material and methods 
Literature review of 95 scientific articles, using the  Pubmed engine has been performed, the 
keywords joining the search were the following: adipokine, atherosclerosis, perivascular 
adipose tissue, adiponectin, leptin. 
 
Results 
 The main adipokines secreted by the adipose tissue  are the proinflammatory cytokines IL-6 and TNF-α, the chemokines IL-
8 and monocyte chemotactic protein-1 (MCP-1) and the hormones leptin, resistin, visfatin,  and adiponectin. Those factors 
can target distant organs such as the  hypothalamus, liver, skeletal muscle and vessels and regulate a plethora of processes 
such as appetite, endothelial function, insulin sensitivity, blood pressure and inflammation. 
Under physiological conditions PVAT, surrounding large arteries and veins, small and resistance vessels, and skeletal muscle 
microvessels, through the secretion of factors such as   adiponectin, omentin-1, vaspin and NO, has potent 
atheroprotective properties (Figure 2).  
Despite the fact that the former is mainly secreted by the adipocytes, its concentration is inversely correlated with the 
adipose tissue mass.  Adiponectin prevents endothelial cells apoptosis and   improves  endothelial function by activating 
eNOS. Through paracrine signaling, adiponectin upregulates NO synthesis in adjacent adipocytes, which would later diffuse 
towards the endothelium.  Moreover, it has antiinflamatory properties thus inhibiting the expression of adhesion 
molecules on endothelial cells and the transformation of macrophages to foam cells. The concentration of adiponectin is 
positively correlated with the level of HDL cholesterol, the responsible mechanism being  the upregulation of ABCA1 (ATP-
binding cassette transporter )  receptors which promote cholesterol efflux from foam cells.  
Obesity, however, is associated with the so-called “obesity triad” consisting of  of hypoxia, inflammation and oxidative 
stress, further leading to a dysregulated production adipokines –a decrease in the secretion of adiponectin, and an 
increase in the concentration of the proinflammatory adipokines: leptin, resistin,  visfatin, IL-6, TNF-α, thus PVAT looses it’s 
atheroprotective function. 
Leptin is an adipokine mainly secreted by adipocytes. Its concentration is directly proportional with the body mass index, 
and is associated with high levels of C-reactive protein, independently of other risk factors. Leptin is involved in several 
stages of atherogenesis by  increasing oxidative stress, stimulating vascular smooth muscle cells migration and 
proliferation, promoting calcification and decreasing arterial distensibility. Moreover it is involved in obesity-associated 
hypertension -another important risk factor for the development of atherosclerosis. 
 Besides leptin, other adypokines secreted by dysfunctional PVAT such as TNF-α and IL-6 induce endothelial expression of 
VCAM-1, ICAM-1 adhesion molecules promoting the adherence  of monocytes, whilst MCP-1 promotes their recruitment 
into the intima. The first two adipokines mentioned above also induce the expression of  resistin. This hormone, thought to 
be involved in insulin resistance,  induces  endothelial dysfunction by inhibiting eNOS and by promoting oxidative stress, 
which further decreases NO bioavailability. Resistin, as well promotes the proliferation and migration of vascular smooth 
muscle cells. It is also involved in foam cell formation due to the fact that it stimulates oxLDL uptake by macrophages 
through the increase in SR-A (scavenger receptor type A ) and CD 36 expression- on one hand,  and  on the other by 
reducing cholesterol efflux through ABCA1 . More than that, it induces plaque destabilization, increasing the risk of its 
rupture and  consequently, thrombus formation. 
 Conclusions 
Since the  discovery of the first adipokine - leptin in 1994, the mechanisms behind the cardiovascular complications of 
obesity gained a better understanding. Adipose tissue synthesizes a series of pro- and anti-inflammatory factors. Obesity is 
associated with the dysregulation of this balance with an increase in the inflammatory tone. Besides the direct impact of 
PVAT and EAT-derived factors on the vascular wall, subcutaneous adipose tissue promotes a  state of low-grade chronic 
inflammation leading to metabolic dysfunction and thus to a proatherosclerotic milieu. Given the extensive data about the 






Fig.2  Atheroprotective properties of PVAT- derived factors 
under physiological conditions. 
Fig.3 Role of dysfunctional PVAT-derived adipokines in  
atherosclerosis development. 
Fig1. Adipokine dysregulation in obesity 
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